@article{1156,
  keywords = {Evaluation framework, Human health, new approach methodologies, Risk Assessment},
  author = {Stanley T. Parish and Michael Aschner and Warren Casey and Marco Corvaro and Michelle R. Embry and Suzanne Fitzpatrick and Darren Kidd and Nicole C. Kleinstreuer and Beatriz Silva Lima and Raja S. Settivari and Douglas C. Wolf and Daiju Yamazaki and Alan Boobis},
  title = {An evaluation framework for new approach methodologies (NAMs) for human health safety assessment},
  abstract = {The need to develop new tools and increase capacity to test pharmaceuticals and other chemicals for potential adverse impacts on human health and the environment is an active area of development. Much of this activity was sparked by two reports from the US National Research Council (NRC) of the National Academies of Sciences, Toxicity Testing in the Twenty-first Century: A Vision and a Strategy (2007) and Science and Decisions: Advancing Risk Assessment (2009), both of which advocated for “science-informed decision-making” in the field of human health risk assessment. The response to these challenges for a “paradigm shift” toward using new approach methodologies (NAMS) for safety assessment has resulted in an explosion of initiatives by numerous organizations, but, for the most part, these have been carried out independently and are not coordinated in any meaningful way. To help remedy this situation, a framework that presents a consistent set of criteria, universal across initiatives, to evaluate a NAM's fit-for-purpose was developed by a multi-stakeholder group of industry, academic, and regulatory experts. The goal of this framework is to support greater consistency across existing and future initiatives by providing a structure to collect relevant information to build confidence that will accelerate, facilitate and encourage development of new NAMs that can ultimately be used within the appropriate regulatory contexts. In addition, this framework provides a systematic approach to evaluate the currently-available NAMs and determine their suitability for potential regulatory application. This 3-step evaluation framework along with the demonstrated application with case studies, will help build confidence in the scientific understanding of these methods and their value for chemical assessment and regulatory decision-making.},
  year = {2020},
  journal = {Regulatory Toxicology and Pharmacology},
  volume = {112},
  pages = {104592},
  month = {2020-04-01},
  issn = {0273-2300},
  url = {https://www.sciencedirect.com/science/article/pii/S0273230020300180},
  doi = {10.1016/j.yrtph.2020.104592},
  language = {en},
}